ZA965749B - Use of allylamines. - Google Patents

Use of allylamines.

Info

Publication number
ZA965749B
ZA965749B ZA9605749A ZA965749A ZA965749B ZA 965749 B ZA965749 B ZA 965749B ZA 9605749 A ZA9605749 A ZA 9605749A ZA 965749 A ZA965749 A ZA 965749A ZA 965749 B ZA965749 B ZA 965749B
Authority
ZA
South Africa
Prior art keywords
pct
date jan
sec
pub
allylamines
Prior art date
Application number
ZA9605749A
Other languages
English (en)
Inventor
Ivan James Dalton Lindley
Neil Stewart Ryder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA965749B publication Critical patent/ZA965749B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
ZA9605749A 1995-07-06 1996-07-05 Use of allylamines. ZA965749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9513750.1A GB9513750D0 (en) 1995-07-06 1995-07-06 Use of allylamines

Publications (1)

Publication Number Publication Date
ZA965749B true ZA965749B (en) 1998-01-05

Family

ID=10777201

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9605749A ZA965749B (en) 1995-07-06 1996-07-05 Use of allylamines.

Country Status (27)

Country Link
US (1) US5935998A (ru)
EP (1) EP0863752B1 (ru)
JP (1) JP3680950B2 (ru)
KR (1) KR100425401B1 (ru)
CN (1) CN1204881C (ru)
AT (1) ATE232723T1 (ru)
AU (1) AU715270B2 (ru)
CA (1) CA2219678C (ru)
CY (1) CY2465B1 (ru)
CZ (1) CZ289440B6 (ru)
DE (1) DE69626301T2 (ru)
DK (1) DK0863752T3 (ru)
ES (1) ES2192608T3 (ru)
GB (1) GB9513750D0 (ru)
HK (1) HK1011527A1 (ru)
HU (1) HU224311B1 (ru)
IL (1) IL122853A (ru)
MX (1) MX9710093A (ru)
MY (1) MY132436A (ru)
NO (1) NO317496B1 (ru)
PL (1) PL187704B1 (ru)
RU (1) RU2193402C2 (ru)
SI (1) SI0863752T1 (ru)
SK (1) SK282874B6 (ru)
TW (1) TW522011B (ru)
WO (1) WO1997002026A1 (ru)
ZA (1) ZA965749B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) * 2002-02-05 2003-08-09 한솔케미언스 주식회사 (ｅ)-터비나핀 또는 이의 염산염의 제조방법
ES2348303T3 (es) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) * 1979-06-08 1980-12-18 Sandoz Ag 2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
DE19975055I1 (de) * 1979-08-22 2000-01-27 Novartis Ag Propenylamine Verfahren zu ihrer Herstellung sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwending als Arzneimittel
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
DE4317449A1 (de) * 1993-05-19 1994-11-24 Asche Ag Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

Also Published As

Publication number Publication date
PL187704B1 (pl) 2004-09-30
SI0863752T1 (en) 2003-06-30
MY132436A (en) 2007-10-31
HUP9802929A2 (hu) 1999-09-28
TW522011B (en) 2003-03-01
HUP9802929A3 (en) 1999-10-28
RU2193402C2 (ru) 2002-11-27
NO975790L (no) 1997-12-09
JP3680950B2 (ja) 2005-08-10
SK282874B6 (sk) 2003-01-09
CA2219678C (en) 2006-10-10
IL122853A0 (en) 1998-08-16
AU715270B2 (en) 2000-01-20
US5935998A (en) 1999-08-10
JPH11508580A (ja) 1999-07-27
HU224311B1 (hu) 2005-07-28
CN1189775A (zh) 1998-08-05
HK1011527A1 (en) 1999-07-16
NO975790D0 (no) 1997-12-09
CY2465B1 (en) 2005-06-03
DE69626301D1 (de) 2003-03-27
SK698A3 (en) 1998-05-06
DK0863752T3 (da) 2003-04-22
EP0863752A1 (en) 1998-09-16
KR19990028725A (ko) 1999-04-15
GB9513750D0 (en) 1995-09-06
CZ289440B6 (cs) 2002-01-16
IL122853A (en) 2001-04-30
KR100425401B1 (ko) 2004-07-16
CZ1798A3 (cs) 1998-03-18
DE69626301T2 (de) 2003-10-16
WO1997002026A1 (en) 1997-01-23
ES2192608T3 (es) 2003-10-16
EP0863752B1 (en) 2003-02-19
CN1204881C (zh) 2005-06-08
AU6519596A (en) 1997-02-05
NO317496B1 (no) 2004-11-08
ATE232723T1 (de) 2003-03-15
CA2219678A1 (en) 1997-01-23
PL323305A1 (en) 1998-03-16
MX9710093A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
MY115662A (en) Novel compounds with analgesic effect
BG106586A (en) Pyrazolopyramidines as therapeutic agents
GR3035621T3 (en) New pyrimidone derivatives with antifungal activity
CY2198B1 (en) 1-Aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
GB9515411D0 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
PL324625A1 (en) Fungicidal compositions
GB9513750D0 (en) Use of allylamines
HUT75115A (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
IL114239A0 (en) Pyrrolidine derivatives their preparation and com¦ositions containing them
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments
GR3021604T3 (en) Application of riluzole as a radiorestorer.
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.
AU1195497A (en) Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.